Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$306.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 7 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 3 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 9 most recent Form 4 transactions.
| Mar 5 | EBS | Emergent BioSolutions Inc. | FTAX | 8,199 | $8.44 | $69.2K | -7.3% | Open the original filing on SEC.gov |
| Mar 3 | EBS | Emergent BioSolutions Inc. | AGRANT◆ | 44,834 | — | — | — | Open the original filing on SEC.gov |
| Mar 1 | EBS | Emergent BioSolutions Inc. | FTAX | 313 | $8.15 | $2.6K | -0.3% | Open the original filing on SEC.gov |
| Feb 6 | EBS | Emergent BioSolutions Inc. | FTAX | 2,852 | $10.92 | $31.1K | -2.5% | Open the original filing on SEC.gov |
| Feb 6 | EBS | Emergent BioSolutions Inc. | DTOISS | 28,847 | $10.92 | $315K | -20.0% | Open the original filing on SEC.gov |
| Oct 7, 2025 | EBS | Emergent BioSolutions Inc. | SSELL◷? | 30,608 | $10.00 | $306.1K | -17.5% | Open the original filing on SEC.gov |
| Jun 8, 2025 | EBS | Emergent BioSolutions Inc. | FTAX | 1,249 | $6.63 | $8.3K | -0.7% | Open the original filing on SEC.gov |